Edition:
United Kingdom

People: Genscript Biotech Corp (1548.HK)

1548.HK on Hong Kong Stock

13.56HKD
7:42am BST
Change (% chg)

HK$0.78 (+6.10%)
Prev Close
HK$12.78
Open
HK$12.90
Day's High
HK$13.60
Day's Low
HK$12.48
Volume
13,500,400
Avg. Vol
13,482,028
52-wk High
HK$34.00
52-wk Low
HK$4.25

Zhu, Li 

Dr. Zhu Li is Vice President - Strategy of the company. since 2010. He is responsible for in-license and new business development and is involved in corporate business strategy. Dr. Zhu worked at Clontech Laboratories, Inc. in California, America as a director of molecular biology from 1990 to 2000. Dr. Zhu worked at Cathay Biotech, Inc. as a vice president of research from July 2006 to December 2008. Dr. Zhu obtained a Bachelor of Science of Biology degree from the East China Normal University in June 1982 and a Doctor of Philosophy from Stanford University in September 1990. Dr. Zhu has not held any directorship in any other public companies the securities of which are or have been listed on any securities market in Hong Kong or overseas in the past three years.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --